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Abstract  
Crystal violet (CV) was incorporated into acrylic latex to produce white light activated 
antimicrobial paint (WLAAP). Measurement of the water contact angle of the WLAAP showed 
that the water contact angle increased with increasing CV concentration. In a leaching test over 
120 h, the amount of CV which leached from the WLAAPs was close to the detection limit 
(<0.03 %). The WLAAPs were used to coat samples of polyurethane and these showed 
bactericidal activity against E. coli which is a key causative agent of healthcare-associated 
infections (HAIs). A reduction in the numbers of viable bacteria was observed on the painted 
coated polyurethane after 6 h in the dark and the bactericidal activity increased with increasing 
CV concentration (P <0.1). After 6 h of white light exposure, all of coated polyurethanes 
demonstrated a potent photobactericidal activity and it was statistically confirmed that the 
WLAAP showed better activity in white light than in the dark (P <0.05). At the highest CV 
concentration, the numbers of viable bacteria fell below the detection limit (<103 CFU/mL) 
after 6h of white light exposure. The difference in antimicrobial activity between the materials 
in the light and dark was 0.48 log at CV 250 ppm and it increased by 0.43 log at each increment 
of CV 250 ppm. The difference was the highest (>1.8 log) at the highest CV concentration 
(1000 ppm).These WLAAPs are promising candidates for use in healthcare facilities to reduce 
HAIs.  
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1. Introduction 
Healthcare-associated infections (HAIs) occur in surgery centers, dialysis centers, and long-
term care facilities such as nursing homes, and community clinics 1. Their effects vary from 
simply discomfort for patients to prolonged or permanent disability and in some cases death 2. 
According to the US Center of Disease Control and Prevention (CDC) in the US, approximately 
4 % of inpatients acquire HAIs, equivalent to 728,000 infections per year, with 75,000 of these 
patients dying during hospitalization 3, 4.   
Since 2008, the CDC has implemented many strategies, including surveillance, inspection, 
and improved guidelines to reduce the rate of HAIs 5-10. In particular, significant effort has been 
dedicated to prevent central line-associated bloodstream infections (CLABSIs), catheter-
associated urinary tract infections (CAUTIs), and surgical site infections (SSIs), meticillin-
resistant Staphylococcus aureus (MRSA) infections, and Clostridium difficile infections. 
Despite these actions, a reduction in infection rates was often not achieved, and in some cases, 
even increased 11.   
Contaminated surfaces in healthcare facilities make an important contribution to HAIs. 
Pathogens are capable of surviving on surfaces of healthcare facilities for several weeks and 
they can be transmitted through touch by healthcare workers and patients 12, 13. Vigorous 
cleaning and disinfection schemes can reduce transmission of healthcare associated pathogens 
14, 15. However, routine cleaning and disinfection is unable to completely remove the pathogens, 
which are adhesive and may reproduce rapidly in favourable conditions 16, 17. Thus, it is 
necessary to develop alternative techniques to prevent or reduce pathogen transmission in 
healthcare facilities.  
Use of antimicrobial surfaces is considered an alternative approach to inhibit the spread of 
HAIs in healthcare facilities as an additional measure to cleaning 18, 19. Many techniques have 
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been suggested for application to soft and hard surfaces, including silver or copper coated 
surfaces 20-22, self-cleaning surfaces 23, 24 and enzyme or bacteriophage immobilized surfaces 
25, 26. In addition, the incorporation of light-activated antimicrobial agents (LAAAs) into 
surfaces is considered a promising technique 27-29. Titanium dioxide (TiO2), a well known 
LAAA, is capable of killing a range of microorganisms including bacteria, fungi, viruses, and 
algae, and it has been studied for application in medical devices such as film, glass, and 
polymers 30-33. The antimicrobial activity of TiO2 is frequently ascribed to OH 
– • radicals and 
other reactive oxygen species (ROS) induced by the light source, causing damage to the 
bacterial cell membrane and cell wall 33. However, TiO2 demonstrates negligible 
photobactericidal activity under white light conditions as it is activated by ultraviolet (UV) 
light which comprises only a small proportion of the total radiation in sunlight and is virtually 
absent in artificial white lighting 34, 35. In order to address this problem, many studies was 
recently performed to enhance photocatalytic efficiency and white light utilization of TiO2 
including using impurity dope and metallization36-38. Previous studies showed that 
incorporation of vanadium or silver and bromine extended photocatalytic range of TiO2 from 
the ultraviolet to the visible region and they showed enhanced antimicrobial activities on 
bacteria under white light condition39, 40.  
Crystal violet (CV), toluidine blue O (TBO), and methylene blue (MB) dyes, which are 
widely used in histological stains and for bacterial classification 41, 42, are also known LAAAs 
showing photobactericidal activity in white light. The dyes generate singlet oxygen (1O2) and 
ROS when they are exposed to the light source 43, and the 1O2 and ROS cause adverse effects 
in bacteria such as loss of membrane integrity, inactivation of enzymes and DNA damage 
resulting in cell death 44-46. The generation of 1O2 and ROS is directly related to light intensity 
47, 48. In addition, the dyes have somewhat lower or no antimicrobial activity in the absence of 
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light 49-51. The antimicrobial activity of CV, TBO, and MB dyes is dependent on their 
concentration, the exposure time, and the intensity of the light source 52, 53. Recent studies from 
our group have investigated the application of CV, TBO, and MB dyes to polymers to generate 
antimicrobial surfaces for use in medical devices including tracheal or urinary catheters and 
tubes for intravenous drips 54, 55. We have shown that the dyes can be readily impregnated into 
polymers using a swell-encapsulation-shrink process, and the polymers showed potent 
photobactericidal activity in white light 44, 55. In addition, incorporation of gold (Au) 
nanoparticles into a dye impregnated polymer significantly enhanced the photobactericidal 
effect 54, 56. 
Although the techniques for synthesis of new materials mentioned above resulted in 
reasonable antimicrobial activity, most of them involve a multi-step process or long-term 
treatment for application to surfaces in healthcare facilities, and they are not applicable to all 
materials. For example, it is difficult for the chemical vapor deposition technique to be applied 
to heat susceptible materials, and the swell-encapsulation-shrink process can be applied only 
to soft polymers such as polyurethane and silicon. In the present study, a white light activated 
antimicrobial paint (WLAAP), which can be easily applied to surfaces in healthcare facilities, 
was developed. The WLAAP consisted of CV and a commercial acrylic latex which is 
commonly used as a component of household paint. The paint was characterized in terms of 
UV-vis absorbance spectra and water contact angle. The novel WLAAP was used to coat 
samples of polyether based thermoplastic polyurethane (PTPU) and antibacterial testing of these 
samples against E. coli showed that the WLAAP possessed significant activity in the dark and 
enhanced activity in the presence of white light.  
2. Materials and Methods 
2.1. Preparation of light activated antimicrobial paint 
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In this study, CV, which is a triarylmethane dye (Figure S1: Supporting information), were 
used to produce a WLAAP. As shown in Figure 1 (a), 100 mg of CV (Sigma-Aldrich, St. Louis, 
MO, USA) was dissolved in 10 mL of DI water and sonicated for 5 min to produce a CV 
solution of 10,000 ppm. With stirring for 5 min, the solution was mixed with acrylic latex 
(X935-33, AzkoNovel, Amsterdam, Netherlands) which is a copolymer of vinyl acetate and 
butyl acrylate. The CV paint solutions were prepared with various CV concentrations: CV 250, 
500, 750, and 1000 ppm.  
2.2. Characterization of crystal violet paint   
For characterization of UV-vis spectra and equilibrium water contact angle of the CV paint, 
1.5 mL of the paint was gently injected onto the surface of glass slides (2.5 × 7.5 cm2), and air-
dried for 24 h in the dark. The coating thickness was approximately 0.3 mm. The UV-vis 
absorption spectra for the paint coated slide glasses were measured using a UV-Vis 
Spectrometer (PerkinElmer Inc., Winter St., CT, USA). Absorption was measured from 400 to 
900 nm.  
The equilibrium water contact angle on the paint coated samples was measured. A droplet 
(~5 µL) of deionised water was dropped onto the surface of the samples by gravity from a 
gauge 27 needle, the samples were photographed side on and the images was analyzed using 
Surftens 4.5 software. 
2.3. Leaching test 
The stability of CV paint in solution was tested. Polyether based thermoplastic polyurethane 
(PTPU, American Polyfilm Inc, Branford, CT, USA) samples (1.5 × 1.5 cm2) were coated by 
0.6 mL of CV paint, and air dried for 24 h in the dark. The coated PTPU samples were placed 
in 5 mL of PBS solution for 120 h. UV-vis spectra of the solutions were periodically measured 
to determine if CV was leaching from the paint into the surrounding solution. The comparison 
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of the absorbance at 590 nm of PBS with a CV calibration curve enabled the determination of 
the released CV concentration.  
2.4. Antimicrobial testing 
For antimicrobial testing, the CV paint coated PTPU samples were used. The antimicrobial 
activities of the samples were tested against E. coli ATCC 25922. The bacteria were stored at 
–70oC in Brain-Heart-Infusion broth (Oxoid Ltd., Hampshire, England, UK) containing 20% 
(v/v) glycerol and propagated on MacConkey agar (Oxoid Ltd., Hampshire, England, UK). 10 
mL of BHI broth was inoculated with one bacterial colony and cultured at 37 o C with shaking 
at 200 rpm. After incubation for 18 h, the bacteria were harvested by centrifugation (21 o C, 
4000 rpm for 20 min), washed using 10 mL of phosphate buffered saline (PBS), and centrifuged 
again to recover the bacteria which were re-suspended in 10 mL of PBS. The washed 
suspension was diluted 1000-fold in order to obtain ~106 colony forming units per millilitre 
(CFU/mL). As shown in Figure 1 (b), 25 µL of bacterial suspension was inoculated on to the 
surface of each sample and a sterile glass cover slip (2.2 × 2.2 cm2) was place on top to ensure 
good contact between the bacteria and the surface of the sample. The samples were loaded into 
petri dishes containing wet filter paper to maintain humidity, and exposed to white light, while 
a control set of samples was kept in the dark. After light exposure, the samples were place into 
5 mL of PBS, and mixed using a vortex mixer for 1 min. The bacterial suspension was diluted, 
plated onto MacConkey agar, and incubated at 37 o C for 24 hours. The colonies that grew on 
the plates were counted. 
2.5 Statistical analyses 
Correlation coefficients, linear regressions, and t-statistics of experimental data were 
calculated using the SPSS statistical software, version 12.0 (SPSS, Inc., Chicago, IL, USA). 
3. Results and discussion 
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Various ratios of CV solution and acrylic latex (polymer) were employed to make WLAAPs, 
as shown Figure 2 (a). The paint changed from white to bright violet by adding CV into the 
acrylic latex, and the colour became more intense with increasing CV concentration. Figure 2 
(b) shows the paint coated glass slides. Glass slides were coated by the paints containing 
different quantities of CV, and then air-dried for 24 h in the dark. After drying, the acrylic latex 
(control) changed from white to colourless, and the CV incorporated paints maintained their 
violet colour. However, in contrast with the solution state samples, the intensity of the paints 
did not increase with increasing CV concentration (250 to 750 ppm). 
The UV-vis absorbance spectra of control and CV paints were measured over the 
wavelengths 400–900 nm. Since the absorbance values of paints containing >CV 250 ppm 
exceeded the detection limit of the UV-Vis Spectrometer, 10-fold diluted CV paints were used 
in this measurement. As shown in Figure 3, the colour intensity of the paints appeared lower 
after dilution. The absorbance spectra showed that all of the CV paints gave a main absorption 
at 590 nm, and the peak intensity and spectrum range of absorbance increased with CV 
concentration. The spectrum curves of the CV paints were different from the results of previous 
studies; the absorbance spectrum of the CV paint gave a normal distribution whereas the 
spectrum of CV incorporated into polymers presented bimodal distribution 54, 56. This is 
probably due to difference in the solvents used. Depending on the type of solvent such as water, 
acetone, and methanol, the CV absorbance spectrum can change with different peak in the 
wavelength range of 500-650 nm 57. Regardless of the CV concentration in the paint, all of the 
paints showed comparable spectra in agreement with results of a previous study 58.  
In order to investigate the change of physical property by combination of crystal violet and 
acrylic latex, the water contact angle of control and CV paints was measured. As shown in 
Figure 4, the control gave water contact angles of 10.9 o. However, the contact angle increased 
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with CV concentration (y = 0.0042x + 10.449, R2 = 0.8487), and it was the highest at CV 1000 
ppm. Compared to the control, the highest increase was approximately 4.2 o at the highest CV 
concentration (P <0.01). This is explained by the fact that the increase of the CV portion in 
acrylic latex contributed to the change of water contact angle because CV is a relatively 
hydrophobic compared to the acrylic latex (control).  
The CV release from the CV paint in PBS solution was determined using a UV-vis 
spectrometer. The CV paint coated PTPU samples were immersed in 5 mL of PBS solution for 
a total of 120 h and the CV release was measured at intervals of 24 h. Figure 5 shows the CV 
release from the paint coated samples to PBS solutions for 120 h. It was confirmed that all of 
paints released some CV into PBS solution after 24 h immersion and that the CV concentration 
was the highest (0.27 ppm) for the paint containing CV 1000 ppm (0.04, 0.07, and 0.14 ppm 
from paints containing CV 250, 500, and 750 ppm, respectively). Over a period of more than 
100 h, additional CV leaching was not detected in all of the CV paints. The total amount of CV 
leached from the paints over a period of 120 h was minor (<0.03 %). 
The antimicrobial testing of CV paint under white light and dark conditions was conducted 
against Escherichia coli which is a key causative agent of HAIs. 25 µL of this bacterial 
suspension, containing 7.8×104 CFU, was inoculated on to the surface of CV paint coated 
PTPU and then exposed to white light or placed in the dark at 20 o C for 6 h. The intensity of 
white light was measured at a distance of 30 cm from the lamp using a lux meter (LX-101, 
Lutron Inc., Coopersburg, PA, USA). The light intensity was the highest at the center and it 
decreased with increasing distance from the center. The intensity of the light ranged from 3900 
to 5300 lux (Figure S2).  
CV dye used in this study as WLAAA has antimicrobial and antifungal activities. It inhibits 
bacterial growth through interaction between positive (GV+) ions dissociated from CV and 
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components of bacterial cells including lipopolysaccharide in the outer membrane of Gram 
negative bacteria, peptidoglycan and DNA 50, 59. As shown in Figure 6 (a), the combination of 
CV and acrylic latex showed antimicrobial activity in the dark. After 6 h in the dark, a 0.12 log 
reduction in the numbers of viable bacteria was observed for CV 250 ppm, compared with the 
control, and the numbers of viable bacteria decreased with increasing CV concentration (R2 = 
0.996, P <0.1) in the paint: 0.31 and 0.49 log reductions were obtained at CV 500 and 750 ppm, 
respectively, and at CV 1000 ppm, a 1.21 log reduction in the numbers of viable bacteria was 
observed. These results indicate that CV keeps its intrinsic antimicrobial property after being 
mixed with acrylic latex. 
Figure 6 (b) shows the antimicrobial activities of CV paint in white light. As in the dark, the 
reduction in the numbers of viable bacteria remaining increased with increasing CV 
concentration after 6 h white light exposure (R2 = 0.811, P <0.1). However, there was a 
statistically significant difference in the total bactericidal activity displayed by the materials in 
the light compared to the dark (comparison of all the concentrations in the light and dark: P 
<0.05). After 6 h of white light exposure, compared with the control, 0.36, 0.43, and 0.86 log 
reductions in the numbers of viable bacteria were observed at CV 250, 500, 750 ppm, and at 
CV 1000 ppm, the numbers of viable bacteria fell below the detection limit (<103 CFU/mL). 
Further, the difference in antimicrobial activity between the materials in the light and dark 
increased with increasing CV concentration in the paint. The difference was 0.48 log at CV 
250 ppm and it increased by 0.43 log at each increment of CV 250 ppm. The difference between 
white light and dark conditions was the highest (>1.8 log) at the highest CV concentration 
(1000 ppm). 
The increase in antibacterial activity of the CV paint in white light can be explained as 
follows: upon white light irradiation of CV paint, CV molecules inside the paint are excited to 
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a triplet state via an intersystem crossing from a slightly higher energy, shorter lived excited 
singlet state. The triplet state dye molecules can undergo one of two photochemical pathways 
44; quenching by molecular oxygen including the production of singlet oxygen (1O2), or 
interaction with biomolecules in the vicinity generating radical species. The generated 1O2 and 
radical species can initiate multi-site attack on bacteria in the vicinity effecting cell death 55.  
Although previous techniques have showed a good antibacterial activity when applied to 
surfaces, these techniques, including chemical vapor deposit, swell encapsulation shrink, and 
physiochemical modification, are not applicable to all substrates. WLAAP developed in this 
study can be easily applied for a wide range of substrates including paper, metal, glass, and 
hard and soft polymers (Figure S3). Moreover, WLAAP is readily fabricable and surface 
treatment using WLAAP is simple and easy. It is expected that WLAAP could be used for 
clinical care facilities including surgery centers, dialysis centers, and nursing homes and also 
applied in the home for decoration, and in toilet and kitchen surfaces. For real world application, 
adverse effects of the paint should be considered. CV has been widely used in medicine for 
over 100 years 50. It poses a very low toxicity risk even in case of administration of high 
quantities 50, 60, however, it has been used in a diluted form as an antiseptic for external wounds 
for a century. Previous studies showed that CV is a useful agent for the elimination of MRSA 
on the skin 61, 62, and it did not produce any serious side effects or mild skin irritation 62. The 
WLAAP showed it in solution leaching test that <0.28 ppm of CV was released from paints 
containing CV 250, 500, 750, 1000 ppm. This is much less than the concentration (lethal dose 
50%: 420 ppm) representing a toxicity in rat oral test 63. Moreover, the amount of CV used in 
WLAAP was relative minor compared to the concentration (20,000 ppm) causing dermal 
irritation or sensitization in long term clinical assessment 64. Thus, it is unlikely that the 
WLAAP we report here will show toxicity towards humans. 
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4. Conclusion 
In this study, CV was incorporated into acrylic latex which is commonly used in household 
paint to produce WLAAP for healthcare or household applications. The combination of CV 
and acrylic latex resulted in a potent WLAAP that not only induced the lethal photosensitization 
(below detection limit at CV 1000 ppm) of E. coli within 6 h, but demonstrated strong 
bactericidal activity (1.21 log reduction in the numbers of viable bacteria at CV 1000 ppm) in 
the dark. Moreover, the CV in the WLAAP was shown to be stable over a 120 h period showing 
minimal leaching into the surrounding solution. It is anticipated that this potent WLAAP will 
be useful in healthcare applications to reduce surface bacterial contamination and thus the 
incidence of HAIs.  
In this study, we did not investigate the amount of generated 1O2 and ROS when WLAAP is 
exposed to what light source, and that which wavelength maximizes the generation. This is 
important to maximize the antimicrobial efficiency of WLAAP under light condition. Thus, we 
are considering an experiment of quantum efficiency measurement in future study. 
Supporting information 
Figure S1. Chemical structure of crystal violet.  
Figure S2. Intesity distribution of white light.  
Figure S3. Image of white light-activated antimicrobial paint coated metal, glass paper, and 
polymers. 
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Figure legends 
Figure 1. (a) Preparation of white light activated antimicrobial paint and (b) antimicrobial 
testing. 
Figure 2. (a) Control and crystal violet paint solutions, and (b) the paint coated glass slides 
Figure 3. UV-vis absorption spectra of control and crystal violet paints. The paints containing 
crystal violet 0, 25, 50, 75, and 100 ppm were coated to glass slides, and they were measured 
within the wavelengths 400–900 nm. 
Figure 4. Water contact angles on the paints containing crystal violet 250, 500, 750, and 1000 
ppm. The paints were coated to polyurethane samples (1.5 × 1.5 cm2) and water contact angles, 
and then water contact angle on them were measured. 
Figure 5. Leaching testing of crystal violet paints in PBS solution. The paints were coated to 
polyurethane samples (1.5 × 1.5 cm2). The samples were immersed in 5 mL of PBS for 120 h.  
Figure 6. Antimicrobial activities of control and crystal violet paints on E. coli bacteria: (a) 6 
h incubation in the dark, and (b) 6 h incubation in white light. Polyurethane samples (1.5 × 1.5 
cm2) were coated using crystal violet paint. E coli was placed in contact with the samples and 
exposed to light intensity ranging from 3900 to 5300 lux. In all tests, the temperature was 
maintained at a constant 20 o C in an incubator.  
Figure S1. Chemical structure of crystal violet 
Figure S2. Intensity distribution of white light which the paint coated samples are irradiated to. 
The intensity was measured at a distance of 30 cm from 28 W hospital fluorescent lamp using 
a lux meter. Colour scale bar corresponds from low (light blue) to high light intensity (light 
purple). 
Figure S3. White light-activated antimicrobial paint coated (a) metal (aluminum), (b) glass, (c) 
paper (d) hard polymer (polystyrene), and soft polymer (polyurethane) plates. 
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Figure 1. (a) Preparation of white light activated antimicrobial paint and (b) antimicrobial 
testing. 
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Figure 2. (a) Control and crystal violet paint solutions, and (b) the paint coated glass slides 
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Figure 3. UV-vis absorption spectra of control and crystal violet paints. The paints containing 
crystal violet 0, 25, 50, 75, and 100 ppm were coated to glass slides, and they were measured 
within the wavelengths 400–900 nm. 
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Figure 4. Water contact angles on the paints containing crystal violet 250, 500, 750, and 1000 
ppm. The paints were coated to polyurethane samples (1.5 × 1.5 cm2) and water contact angles, 
and then water contact angle on them were measured. 
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Figure 5. Leaching of CV from paints into PBS solution. The paints were coated on to 
polyurethane samples (1.5 × 1.5 cm2) which were immersed in 5 mL of PBS for 120 h.  
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Figure 6. Antimicrobial activity of control and crystal violet paints against E. coli: (a) 6 h 
incubation in the dark, and (b) 6 h incubation in white light. Polyurethane samples (1.5 × 1.5 
cm2) was coated using crystal violet paints. E coli was placed in contact with the samples and 
exposed to light intensity ranging from 3900 to 5300 lux. In all tests, the temperature was 
maintained at a constant 20 o C.  
1 Colony forming unit/ mL 
Below detection limit of 1000 CFU 
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